ARCT-810

N/A

Report date: 2026/05/13 15:37:31

Base Information

Drug NameARCT-810
Drug Alias NameLUNAR-OTCARCT-810
ClassificationCell and gene therapy > Gene therapy > mRNABiologics
Mechanisms of ActionEnzyme replacementsOrnithine carbamoyltransferase stimulants
TargetsOrnithine carbamoyltransferase
Therapy Area/IndicationsOrnithine Carbamoyltransferase Deficiency Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumUnited StatesSweden +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCurevac AgArcturus Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesArcturus Therapeutics IncCurevac Ag
Inactive CompaniesN/A
Active IndicationsOrnithine Carbamoyltransferase Deficiency Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A